Literature DB >> 28253514

ENETS Consensus Guidelines for the Standards of Care in Neuroendocrine Tumors: Pre- and Perioperative Therapy in Patients with Neuroendocrine Tumors.

Gregory Kaltsas1, Martyn Caplin, Philippa Davies, Diego Ferone, Rocio Garcia-Carbonero, Simona Grozinsky-Glasberg, Dieter Hörsch, Eva Tiensuu Janson, Reza Kianmanesh, Beata Kos-Kudla, Marianne Pavel, Anja Rinke, Massimo Falconi, Wouter W de Herder.   

Abstract

Entities:  

Year:  2017        PMID： 28253514      PMCID： PMC5637287          DOI： 10.1159/000461583

Source DB:  PubMed          Journal:  Neuroendocrinology        ISSN： 0028-3835            Impact factor:   4.914


× No keyword cloud information.
  58 in total

Review 1.  Perioperative management of selected endocrine disorders.

Authors:  G W Graham; B P Unger; D B Coursin
Journal:  Int Anesthesiol Clin       Date:  2000

2.  Carcinoid syndrome: its relevance to the anaesthetist.

Authors:  R A Mason; P A Steane
Journal:  Anaesthesia       Date:  1976-03       Impact factor: 6.955

3.  Carcinoid tumor and carcinoid syndrome.

Authors:  Stephen F Dierdorf
Journal:  Curr Opin Anaesthesiol       Date:  2003-06       Impact factor: 2.706

4.  Surgical management of left-sided carcinoid heart disease.

Authors:  H M Connolly; H V Schaff; C J Mullany; J Rubin; M D Abel; P A Pellikka
Journal:  Circulation       Date:  2001-09-18       Impact factor: 29.690

5.  Perianaesthetic risks and outcomes of abdominal surgery for metastatic carcinoid tumours.

Authors:  M A Kinney; M E Warner; D M Nagorney; J Rubin; D R Schroeder; P M Maxson; M A Warner
Journal:  Br J Anaesth       Date:  2001-09       Impact factor: 9.166

Review 6.  Epidemiology, clinical features and diagnosis of gastroenteropancreatic endocrine tumours.

Authors:  P Tomassetti; M Migliori; S Lalli; D Campana; V Tomassetti; R Corinaldesi
Journal:  Ann Oncol       Date:  2001       Impact factor: 32.976

Review 7.  Prognosis of patients with carcinoid heart disease after valvular surgery.

Authors:  Imthiaz Manoly; Sarah-Louise McAnelly; Sanjeevan Sriskandarajah; Kenneth Edward McLaughlin
Journal:  Interact Cardiovasc Thorac Surg       Date:  2014-05-08

8.  Endocrine pancreatic tumors with glucagon hypersecretion: a retrospective study of 23 cases during 20 years.

Authors:  Henrik Kindmark; Anders Sundin; Dan Granberg; Kristina Dunder; Britt Skogseid; Eva Tiensuu Janson; Staffan Welin; Kjell Oberg; Barbro Eriksson
Journal:  Med Oncol       Date:  2007       Impact factor: 3.064

Review 9.  Hepatic surgery for metastases from neuroendocrine tumors.

Authors:  Juan M Sarmiento; Florencia G Que
Journal:  Surg Oncol Clin N Am       Date:  2003-01       Impact factor: 3.495

Review 10.  Pharmacotherapy of Zollinger-Ellison syndrome.

Authors:  Tetsuhide Ito; Hisato Igarashi; Hirotsugu Uehara; Robert T Jensen
Journal:  Expert Opin Pharmacother       Date:  2013-01-30       Impact factor: 3.889
View more
  29 in total

1.  Neuroendocrine neoplasms - still a challenge despite major advances in clinical care with the development of specialized guidelines.

Authors:  Stephan Petersenn; Christian A Koch
Journal:  Rev Endocr Metab Disord       Date:  2017-12       Impact factor: 6.514

Review 2.  Modern therapeutic approaches for the treatment of malignant liver tumours.

Authors:  Henrik Petrowsky; Ralph Fritsch; Matthias Guckenberger; Michelle L De Oliveira; Philipp Dutkowski; Pierre-Alain Clavien
Journal:  Nat Rev Gastroenterol Hepatol       Date:  2020-07-17       Impact factor: 46.802

Review 3.  Supportive therapy in gastroenteropancreatic neuroendocrine tumors: Often forgotten but important.

Authors:  Xi-Feng Jin; Matilde P Spampatti; Christine Spitzweg; Christoph J Auernhammer
Journal:  Rev Endocr Metab Disord       Date:  2018-06       Impact factor: 6.514

Review 4.  The Evolution of Neuroendocrine Tumor Treatment Reflected by ENETS Guidelines.

Authors:  Wouter T Zandee; Wouter W de Herder
Journal:  Neuroendocrinology       Date:  2018-01-10       Impact factor: 4.914

Review 5.  Liver-Directed Therapy for Neuroendocrine Tumor Liver Metastases in the Era of Peptide Receptor Radionuclide Therapy.

Authors:  Evan D Lehrman; Nicholas Fidelman
Journal:  Semin Intervent Radiol       Date:  2020-12-11       Impact factor: 1.513

Review 6.  Shifting Paradigms in the Pathophysiology and Treatment of Carcinoid Crisis.

Authors:  Jessica E Maxwell; Boris Naraev; Daniel M Halperin; Michael A Choti; Thorvardur R Halfdanarson
Journal:  Ann Surg Oncol       Date:  2022-02-14       Impact factor: 5.344

7.  Novel scoring system guiding the incorporation of adjuvant RT for neuroendocrine neoplasms treated with surgical resection followed by chemotherapy.

Authors:  Jeanny Kwon; Byoung Hyuck Kim
Journal:  J Cancer Res Clin Oncol       Date:  2022-09-17       Impact factor: 4.322

Review 8.  Curative and palliative surgery in patients with neuroendocrine tumors of the gastro-entero-pancreatic (GEP) tract.

Authors:  Peter E Goretzki; Martina T Mogl; Aycan Akca; Johann Pratschke
Journal:  Rev Endocr Metab Disord       Date:  2018-06       Impact factor: 6.514

Review 9.  Carcinoid Syndrome and Hyperinsulinemic Hypoglycemia Associated with Neuroendocrine Neoplasms: A Critical Review on Clinical and Pharmacological Management.

Authors:  Francesca Spada; Roberta E Rossi; Elda Kara; Alice Laffi; Sara Massironi; Manila Rubino; Franco Grimaldi; Sherrie Bhoori; Nicola Fazio
Journal:  Pharmaceuticals (Basel)       Date:  2021-06-04

Review 10.  Antiproliferative Systemic Therapies for Metastatic Small Bowel Neuroendocrine Tumours.

Authors:  Mohammed Dawod; Teresa Alonso Gordoa; Mauro Cives; Louis De Mestier; Joakim Crona; Francesca Spada; Kjel Oberg; Marianne Pavel; Angela Lamarca
Journal:  Curr Treat Options Oncol       Date:  2021-06-29
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.